Search

everythinglearnresearchcommunity

for

Search:↓

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

JAK inhibitors might help treat alopecia areata.

Ginsenoside Rg3 may help hair growth by increasing a growth-related protein in hair cells.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.